Mathematical Models of the Complete Course of HIV Infection and AIDS

Mathematical models of HIV infection are important to our understanding of AIDS. However, most models do not predict both the decrease in CD4+ T cells and the increase in viral load seen over the course of infection. By including terms for continuous loss of CD4+ T cells and incorporating alteration in viral clearance and viral production, two new models have been created that accurately predict the dynamics of the disease. The first model is a clearance rate reduction model and is based on a 10% per year decrease in both viral clearance and CD4+ T cell levels. A macrophage reservoir model incorporating the observation that macrophage viral production increases up to 1000 fold in the presence of opportunistic infections that become increasingly common as disease progresses. Both viral clearance and macrophage reservoir models predict the expected decrease in T cell levels and rise in viral load observed at the onset of AIDS.

[1]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[2]  D. Weissman,et al.  Immunopathogenic mechanisms of HIV infection. , 1996, Annals of internal medicine.

[3]  A S Perelson,et al.  Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.

[4]  C. Fox,et al.  Macrophages as a source of HIV during opportunistic infections. , 1997, Science.

[5]  A. Haase,et al.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.

[6]  Louis J. Picker,et al.  Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.

[7]  R. M. Zorzenon dos Santos,et al.  Dynamics of HIV infection: a cellular automata approach. , 2001, Physical review letters.

[8]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[9]  Daniel C. Douek,et al.  Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection1 , 2001, The Journal of Immunology.

[10]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[11]  M A Nowak,et al.  Dynamics of macrophage and T cell infection by HIV. , 1999, Journal of theoretical biology.

[12]  W Turner,et al.  Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. , 1998, The Journal of clinical investigation.

[13]  D. Ho,et al.  HIV-1 dynamics in vivo. , 1995, Journal of biological regulators and homeostatic agents.

[14]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[15]  M. Hirsch,et al.  Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.

[16]  Sebastian Bonhoeffer,et al.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.

[17]  J. Mcdougal,et al.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). , 1986, Journal of immunology.

[18]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[19]  Alan S. Perelson,et al.  Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.

[20]  M. Lederman,et al.  Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. , 1994, Journal of acquired immune deficiency syndromes.

[21]  M A Nowak,et al.  Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N Bischofberger,et al.  Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[24]  J. Justement,et al.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Gendelman,et al.  Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. , 1991, Journal of immunology.

[26]  M Kapadvanjwala,et al.  A mathematical simulation of the AIDS patient and extracorporeal detoxification. , 1989, Computers in biology and medicine.

[27]  F. Miedema,et al.  In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro. , 1998, The Journal of infectious diseases.

[28]  G. Eddy,et al.  Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques. , 1994, AIDS research and human retroviruses.

[29]  A S Perelson,et al.  Improved estimates for HIV-1 clearance rate and intracellular delay. , 1999, AIDS.

[30]  A. Perelson,et al.  Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. , 1999, The New England journal of medicine.

[31]  A. Merzouki,et al.  T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide , 2000, Journal of Virology.

[32]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[33]  Pei Yu,et al.  Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy , 2001, Comput. Biol. Medicine.